BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 32444962)

  • 1. Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.
    Cui Y; Yan M; Zhang C; Xue J; Zhang Q; Ma S; Guan F; Cao W
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):1993-2006. PubMed ID: 32444962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma.
    Cui Y; Zhang C; Wang Y; Ma S; Cao W; Guan F
    Life Sci; 2020 Feb; 243():117230. PubMed ID: 31923422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma.
    Cui Y; Zhang C; Li Y; Ma S; Cao W; Guan F
    Cell Biol Int; 2021 Jun; 45(6):1246-1259. PubMed ID: 33559901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diagnostic and Prognostic Values of HOXA Gene Family in Kidney Clear Cell Renal Cell Carcinoma.
    Zong X; Fu J; Wang Z; Wang Q
    J Oncol; 2022; 2022():1762637. PubMed ID: 35342423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
    Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
    Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
    Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
    Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
    Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
    Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
    Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
    Xing Q; Ji C; Zhu B; Cong R; Wang Y
    Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics.
    Wu H; Liu M; He Y; Meng G; Guo W; Guo Q
    BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
    Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
    Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-138-5p inhibits proliferation and invasion in kidney renal clear cell carcinoma by targeting SINA3 and regulation of the Notch signaling pathway.
    Liu Y; Qu HC
    J Clin Lab Anal; 2021 Nov; 35(11):e23766. PubMed ID: 34586647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Expression and Prognosis Value of COG Complex Members in Kidney Renal Clear Cell Carcinoma (KIRC).
    Zhang Y; Lai H; Tang B
    Dis Markers; 2021; 2021():4570235. PubMed ID: 34539936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MKRN1/2 serve as tumor suppressors in renal clear cell carcinoma by regulating the expression of p53.
    Yang Y; Luo Y; Huang S; Tao Y; Li C; Wang C
    Cancer Biomark; 2023; 36(4):267-278. PubMed ID: 36938725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Zou X; Mo Z
    Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troponin T1 in tumorigenesis and immune modulation: Insights into multiple cancers and kidney renal clear cell carcinoma.
    Zhang Q; Hao L; Wang F; Yu Q; Wu S; Han C
    J Cell Mol Med; 2024 Jun; 28(11):e18410. PubMed ID: 38853457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
    Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.
    Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T
    BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.